Now, a board-certified anesthesiologist in Los Angeles is revealing five daily medications that may also increase your likelihood of developing dementia, a group of brain disorders that affects ...
Lilly’s solanezumab famously failed to produce significant results in early stage Alzheimer’s late last year, the latest in a long list of drugs that have come up short in trials. George ...
Axsome Therapeutics said it would submit its Alzheimer’s disease treatment for FDA approval despite mixed results from two ...
Prof Sir John Hardy is chairman of molecular biology of neurological disease at the UCL Institute of Neurology - Paul Grover for the Telegraph Alzheimer’s drugs should be prescribed like statins ...
The federal Food & Drug Administration has approved two new Alzheimer’s medications that can offer people more time to live normally, but accessing them in Florida is complicated. Hold-ups ...
It's possible that Alzheimer's disease could be added to the lengthening list of health conditions that ... stage Alzheimer's has shown that the drug was able to reduce shrinking in the areas ...
One of the most intriguing is a late-stage trial of semaglutide in Alzheimer’s patients ... with the drugs available at a large discount to the list price. Side-effects including nausea ...